Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Phytoteq Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. Both of these actions are assigned to 1 distinct examiner, SHARMA, SANTOSH. These filings are distributed across 2 distinct art units, which means the single examiner is reviewing applications categorized in different technical subgroups within the broader field.
SHARMA, SANTOSH is the busiest examiner for this portfolio, with 2 pending office actions currently under review. Because there is only 1 distinct examiner for the 2 pending office actions, this individual has total oversight of the company's active prosecution. The 2 distinct art units indicate that the subject matter, while handled by one person, spans different administrative divisions.
The concentration of 2 pending office actions under 1 distinct examiner simplifies the point of contact for Phytoteq Inc. However, the involvement of 2 distinct art units suggests that the examiner is applying expertise across multiple technical classifications. Practitioners should monitor how the busiest examiner handles the 2 pending office actions to identify any consistency in examination across the 2 distinct art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHARMA, SANTOSH | 2 | 72.8% | +29.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19182557 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | SHARMA, SANTOSH | — |
| 17982444 | METHOD FOR PRODUCING SUGAR FROM AGAVE CULTURES | SHARMA, SANTOSH | — |
| Art Unit | Apps |
|---|---|
| 1661 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19182557 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | SHARMA, SANTOSH | 1661 | §112Other | Non-Final OA | — | Pending | Apr 17, 2025 |
| 17982444 | METHOD FOR PRODUCING SUGAR FROM AGAVE CULTURES | SHARMA, SANTOSH | 1663 | §103DP | Non-Final OA | — | Pending | Nov 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPhytoteq Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 1 examiners.
Santosh Sharma has the most, with 2 of Phytoteq Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
